Parkinson's Disease: World Drug Market 2011-2021VisiongainSeptember 26, 2011 142 Pages - SKU: VSG6653333 |
Additional Information
Report Excerpt
5.7 Rest of the World: Market Forecast 2011-2021
The revenues of the ‘Rest of the World’ market are predominantly derived from the developed markets of the Anglosphere, particularly New Zealand, Australia, and Canada, although the other two BRIC (Brazil, Russia, India and China) countries are also showing strong growth.
Companies Listed
Abbott Laboratories
Acadia Pharmaceuticals
Amgen
Axxonis Pharma
Biotie
BioSante Pharmaceuticals
Biovail
Boehringer Ingelheim
Brainstorm Cell Therapeutics
Buck Institute for Research on Aging
Ceregene
Chelsea Therapeutics
Ciba-Geigy
Cipla
Columbia University
Dainippon Sumitomo
Dresden University of Technology
Eisai
EMEA/EMA
Endo Pharmaceuticals
Erba
Farmitalia Carlo
FDA [US]
Impax Laboratories
GlaxoSmithKline
Ipsen
Juvantia Pharma
Kaneka Nutrients
Kyowa Hakko Kirin
Lundbeck
Maypro Industries
Merck & Co.
Merck KGaA
Merck Serono
Mitsubishi Gas Chemical
Mylan
National Institute of Neurological Disorders and Stroke [NINDS]
Neupro
Neurologix
Newron Pharmaceuticals
NINDS
Novartis
Orion
Oxford BioMedica
Pacific Rainbow International
Parkinson's UK
Parr
Pfizer
Pharmacia
Roche
Roxane
Sandoz
Santhera
Schering Plough
Servier
ShenZhou Biology & Technology
Solvay Pharmaceuticals
Sun Pharmaceuticals
Synergen Corporation
Synosia Therapeutics
Teva Pharmaceutical Industries
UCB
University of Bristol Institute of Clinical Neuroscience
University of Kentucky
University of Nebraska
University of Rochester
Valeant
Watson Pharmaceuticals
Weill Medical College, Cornell University
Wockhardt
Xenoport
Xiamen Kingdomway Group
Zhejiang Medicine Company
More Parkinson's Disease reports by Visiongain
Neuroprotective Products: World Market Prospects 2012-2022 by Visiongain
See all reports like this >>What are the commercial prospects for neuroprotective treatments? Visiongain's new report shows you potential revenues and trends to 2022, discussing data, opportunities and outlooks.
...
More Global Parkinson's Disease reports
Parkinson's Disease Global Clinical Trials Review, H2, 2012 by GlobalData
Parkinson's Disease Global Clinical Trials Review, H2, 2012SummaryGlobalData's clinical trial report, “Parkinson’s Disease Global Clinical Trials Review, H2, 2012\ provides data on the Parkinson’s Disease ...
Vaccines 2012-16 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments by Kalorama Information
This report examines the market for vaccines used in humans to previous various types of disease. It covers only commercialized vaccines and developmental vaccines for ...
Global Markets for Treatments of Dementia and Movement Disorders - Focus on Movement Disorders by BCC Research
The global market for treatments for syndromes of dementia and movement disorders was valued at $10.5 billion in 2011 and should reach $11.1 billion in ...
Analyzing the Global CNS Market by Aruvian's R'search
See all reports like this >>The CNS market at a global scale is one of the largest and fastest growing markets in the pharmaceutical industry. Reimbursement terms remain favorable within ...
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Parkinson's Disease Reports
- Neurodegenerative Diseases Market to 2018 - New product entries in both niche and broader Parkinson’s disease treatment will boost market despite patent cliff
- Parkinson's Disease – Pipeline Review, H1 2013
- Parkinson's Disease Global Clinical Trials Review, H2, 2012
- Vaccines 2012-16 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments
- Market and Product Forecasts: Top 10 Neurology Brands 2011–21
